PQE Group Reports Solid Year-End Results, Strengthens Position through Innovation in Pharmaceuticals and Medical Devices
27.1.2026 15:00:00 CET | Business Wire | Press Release
2025 represented another successful year for PQE Group, a consulting firm in the Life Sciences industry based in Florence (Italy) that includes more than 2000 employees and 40+ offices worldwide. Recently named "Best Managed Company" by Deloitte Private for the sixth consecutive year, the Group achieved a rise in revenue, which reached € 105 millions in 2025, an increase of 7% compared to the €97,5M millions realized in 2024.
Founded by CEO Gilda D'Incerti in 1998, PQE Group is a women-owned company that has received numerous industry certifications, including ISO/IEC 27001, which is the world's best-known standard for information security, and ISO 9001, which focuses on quality management systems. To enhance its ongoing global expansion efforts, in 2025 PQE further expanded in the APAC Region, continued to strengthen its presence in North America, and established new offices in Latina, Italy and Copenhagen, Denmark. PQE also deepened its commitment to Artificial Intelligence (AI) in 2025, focusing heavily on PQE’s AI and Cybersecurity Services excellence and allocating significant resources to stay abreast of AI technological advancements, trends, and offerings in the Life Sciences industry.
In addition to receiving Deloitte Private’s Best Managed Company 2025 Award, PQE’s achievements and recognitions throughout the year included: Great Place to Work Certification for its US Subsidiary for the fourth consecutive year; Best Life Science Company in Maryland by Stellar Business Awards; Ecovadis Badge for Sustainability Excellence 2026; and recognition among the top 75 ESG performers at the Sustainability Award 2025, receiving the 2025 Sustainability Award Italy, which recognizes PQE’s commitment to ESG, the goals of which are published in its Sustainability Report each year, thereby disclosing detailed information on PQE’s sustainability strategy.
In 2025, PQE enhanced its already knowledgeable, professional SME staff by hiring additional senior level consultants and industry experts in numerous service areas, including the recent appointment of Francesco Minà as new Vice President Operations, who, after two decades spent working in the field of Automation and Operational Excellence for Johnson & Johnson, will now lead the service delivery of PQE Group at global level.
“2025 has been a positive year for PQE Group, a private company, made in Italy, with an international dimension,” said Gilda D’Incerti, PQE Group’s CEO & Founder. “This allows us to be in competition with the biggest consulting companies,” she continued, “and not only because of our global network and substantial number of highly specialized resources. By continuously monitoring industry trends and evolving technologies, we provide high-level solutions at competitive costs, pairing local responsiveness with global expertise, and we are quickly becoming one of the top worldwide consulting companies in the biopharmaceutical and medical device industries.”
As PQE continues to expand its global network, it is very committed to investing in expertise and knowledgeable professionals, delivering innovative and impactful solutions for its clients worldwide, and giving back through meaningful social responsibility initiatives— alongside an on-going commitment to patients’ safety and constant efforts to positively enhance the Life Science industry. On this note, the company is a proud member of the EU-funded Project-COMFORT Consortium that aims to transform healthcare through Patient Centric micro-Sampling (PCmS), a minimally invasive method for collecting and analyzing blood samples outside traditional clinical settings. For this effort, PQE is currently leading the “Work Package 7: Laying the Foundation for the Future”, to engage with the project’s audiences by sharing insights, updates, and outputs such as reports and publications.
About PQE Group
Established in Florence, Italy, in 1998, PQE Group is a woman-owned leading Life Science consulting firm, providing high-quality solutions in GCP, GLP, GMP, and GDP areas to both industry giants and small-mid-size businesses worldwide. With a focus on innovation, efficiency, and sustainability and with a global presence through its 40+ offices located around the world and 2000+ professional employees, PQE Group continues to set industry benchmarks and drive positive change in the Life Science sector. The Group's CEO & Founder, Gilda D'Incerti, has also launched ReSQ-UP, a groundbreaking initiative in the Clinical Research Organizations field, focusing on supporting emerging startups in women's health (FemTech), medical devices, and innovations in the biotech sector.
Visit us at PQE Group: Home - PQE Group , and follow PQE Group on LinkedIn, Instagram and Facebook
Learn more about Project-COMFORT: Home – Project-COMFORT, and follow us on LinkedIn
View source version on businesswire.com: https://www.businesswire.com/news/home/20260127299159/en/
Contacts
PQE Group Press Office | Contacts: press@pqegroup.com
PQE Global
Debra J. Kaufmann
d.kaufmann@pqegroup.com
Mobile Phone – US : +240-704-0550
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Emdoor Information Marks 18 Years of Rugged Computing Excellence with Vertically Integrated Capabilities10.10.2026 12:30:00 CEST | Press Release
As industrial automation, smart manufacturing, and field operations increasingly depend on mission-critical mobile computing, global demand for reliable rugged tablets, rugged laptops, and rugged handhelds continues to accelerate. Emdoor Information, a publicly listed company on China’s A-share main board since 2023 and an 18-year veteran in rugged computing, has established itself as a rugged computing solutions provider for industrial customers worldwide. Founded in 2008, the company delivers sustained growth, world-class manufacturing, resilient supply chains, full-stack R&D, and comprehensive lifecycle services. Its rugged computing products and industrial customers now span North America, Latin America, Europe, and Asia-Pacific, serving sectors such as public utilities, intelligent manufacturing, warehouse management, transportation, energy industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261010564561/en/ Rugged
Vertex to Present New Data on ALYFTREK ® at the North American Cystic Fibrosis Conference9.10.2026 19:15:00 CEST | Press Release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced new interim data from the ALYFTREK® (vanzacaftor/tezacaftor/deutivacaftor) 2 to 5 years old open-label extension study, highlighting recovery of exocrine pancreatic function in some children in that age group, allowing those children to discontinue pancreatic enzyme replacement therapy (PERT). Pancreatic exocrine insufficiency in children with cystic fibrosis (CF) was previously believed to be irreversible. These data were presented at the North American Cystic Fibrosis Conference (NACFC). “The data presented at NACFC underscore the safety and efficacy of our CF medicines in the real world and in clinical trials in younger age groups. The data from the Phase 3 open-label study in 2 to 5 year olds evaluating exocrine pancreatic function represent a profound shift in how we understand the benefits of treating cystic fibrosis in its earliest stages,” said Carmen Bozic, M.D., Executive Vice President, Global Medicines Devel
Verdant Rock Receives A (low) Financial Strength Rating from Morningstar DBRS, Adding a Second International Investment-Grade Assessment9.10.2026 16:00:00 CEST | Press Release
Verdant Rock Limited, a Bermuda Monetary Authority-regulated Class 3B insurance company, has received an A (low) Financial Strength Rating from Morningstar DBRS. The rating reflects Verdant Rock’s financial strength and its capacity to meet policyholder obligations as an investment-grade financial guarantor for Emerging Markets credit. Morningstar DBRS is a global credit rating agency with coverage across North America, Europe, Asia, and Latin America. Its assessment of Verdant Rock reflects the company’s strong projected earnings ability, robust risk profile, sound liquidity, and good capitalization. Morningstar DBRS also assigned an A (low) Issuer Rating to Verdant Rock. The rating follows Verdant Rock’s BBB+ Long-Term Insurer Financial Strength Rating with a Stable Outlook from Fitch Ratings, assigned on 12 June 2026. Verdant Rock now holds Financial Strength Ratings from both Fitch Ratings and Morningstar DBRS, providing counterparties with dual-agency confirmation of the company’s
Tecnotree Named a Visionary in the Inaugural 2026 Gartner® Magic Quadrant™ for CSP AI-Enabled Marketing and Sales Solutions9.10.2026 15:17:00 CEST | Press Release
Tecnotree, a global digital platform and services leader for AI, 5G, and cloud-native technologies, today announced that Gartner has positioned it as a Visionary in the first-ever Magic Quadrant for AI-Enabled CSP Marketing and Sales Solutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261009905430/en/ Tecnotree Named a Visionary in the Inaugural 2026 Gartner® Magic Quadrant™ for CSP AI-Enabled Marketing and Sales Solutions A new category for a new operating model. CSPs are fighting saturated markets, rising acquisition costs, and accelerating churn. They are responding with AI-driven automation across the full revenue cycle, from segmentation and campaigns to lead management, CPQ, and renewals, increasingly executed by autonomous agents. According to us, Gartner creation of this Magic Quadrant confirms the shift has moved from pilot to boardroom priority. According to Gartner, Visionaries "understands where the market
Positive New Data on Corcym’s Perceval Plus Sutureless Aortic Heart Valve Encompasses up to 7-Year Follow-up9.10.2026 15:15:00 CEST | Press Release
Corcym, a global medical device company dedicated to cardiac surgery, today announced that positive mid-term data from a sub-analysis of its Perceval Plus sutureless aortic heart valve as part of its MANTRA clinical trial was featured in an oral presentation today at the annual meeting of the European Association for Cardio-Thoracic Surgery (EACTS). The study is the longest follow-up available for Perceval Plus and the FREE tissue treatment from an international multicenter study, and demonstrated excellent durability, safety and quality of life improvements. Perceval Plus is the only sutureless and collapsible aortic surgical heart valve. Its unique design performs in any surgical scenario and is optimal for endoscopy and robotics. The valve features the company’s FREE next generation tissue treatment addressing the two main causes of calcification, phospholipids and aldehydes. Its proprietary LANCELOT advanced manufacturing process includes zero-pressure shaping and laser cutting of
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom